SARS-CoV-2 (COVID-19) Spike RBD Monoclonal Antibody [B002] | 10-555

SARS-CoV-2 (COVID-19) Spike RBD Monoclonal Antibody [B002] | 10-555 | Gentaur UK, US & Europe Distribution

Host: Human

Reactivity: Virus

Homology: N/A

Immunogen: S-RBD recombinant protein

Research Area: Infectious Disease, COVID-19

Tested Application: E, WB, Neut

Application: ELISA: ECD-1:320000, RBD-1:80000; WB: 1:1000~2000

Specificiy: N/A

Positive Control 1: N/A

Positive Control 2: N/A

Positive Control 3: N/A

Positive Control 4: N/A

Positive Control 5: N/A

Positive Control 6: N/A

Molecular Weight: N/A

Validation: N/A

Isoform: N/A

Purification: Greater than 95% as determined by reducing SDS-PAGE.

Clonality: Monoclonal

Clone: N/A

Isotype: N/A

Conjugate: Unconjugated

Physical State: Liquid

Buffer: PBS with 0.02% sodium azide, 10% glycerol, pH7.2

Concentration: batch dependent

Storage Condition: Store at 4˚C short term. Aliquot and store at -20˚C long term. Avoid freeze-thaw cycles.

Alternate Name: SARS-CoV-2 (COVID-19, 2019-nCoV) Spike Antibody: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) , Surface Glycoprotein, Spike protein

User Note: Optimal dilutions for each application to be determined by the researcher.

BACKGROUND: SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases. SARS CoV-2 Spike Protein derived from 2019-nCoV is composed of S1 domain and S2 domain. The S1 contains a receptor-binding domain (RBD) that can specifically bind to angiotensin-converting enzyme 2 (ACE2) , the receptor on target cells.